GlassScriptPhysician profile
James Anthony Kim
NPI 1720249691
$13,091.80
in general payments reported to CMS, 2019-2025
31 companies · $2,640 in 2025
The $2,640 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,212 · 2020: $909 · 2021: $1,511 · 2022: $3,095 · 2023: $915 · 2024: $2,810 · 2025: $2,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,936 · Travel and Lodging: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,935.92 |
| Travel and Lodging | $428.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,001.46 | 2019-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $2,677.27 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Medtronic, INC. | $2,521.40 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $673.52 | 2019-2020 | |
| Nalu Medical, INC. | $564.18 | 2021-2022 | |
| Ibsa Pharma INC. | $495.22 | 2020-2025 | Tirosint, Licart, Tirosint |
| Electronic Waveform Lab, INC. | $469.29 | 2023-2025 | |
| Si-Bone, INC. | $469.19 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $431.59 | 2021-2023 | |
| Nevro Corp. | $263.52 | 2019-2020 | |
| Abbvie INC. | $185.57 | 2022-2023 | |
| Vertos Medical, INC. | $170.99 | 2022 | |
| Vertiflex, INC. | $163.47 | 2019 | |
| Tersera Therapeutics LLC | $126.14 | 2019-2021 | |
| Avanos Medical | $123.14 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $82.27 | 2023 | Evoke Scs |
| Biohaven Pharmaceuticals, INC. | $76.54 | 2021 | |
| Collegium Pharmaceutical, INC. | $75.74 | 2020-2022 | |
| Globus Medical, INC. | $73.46 | 2025 | Senza, Vyrsa V1 |
| Pfizer INC. | $69.52 | 2019-2024 | |
| Allergan, INC. | $54.38 | 2020-2022 | |
| Biotronik Nro, INC. | $51.95 | 2025 | Prospera |
| Sumitomo Pharma America, INC. | $48.32 | 2025 | Gemtesa |
| Relievant Medsystems, INC. | $44.52 | 2021-2023 | Intracept |
| Mml US, INC. | $37.08 | 2025 | Reactiv8 |
| Merit Medical Systems INC | $28.76 | 2022 | |
| Lilly USA, LLC | $26.22 | 2023 | Mounjaro |
| Orthogenrx INC. | $25.00 | 2020 | |
| Tactile Systems Technology INC | $23.55 | 2023 | Flexitouch Plus, Entre Plus |
| Novo Nordisk INC | $23.36 | 2024 | Rybelsus, Ozempic |
| Flowonix Medical Incorporated | $15.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.